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Background: Chronic obstructive pulmonary disease (COPD) has significant systemic effects that substantially
impact quality of life and survival. The purpose of this study was to assess and compare peripheral muscle strength
and endurance, exercise capacity, fatigue perception and quality of life between patients with COPD and healthy
subjects.
Methods: Twenty COPD patients (mean FEV1 49.3 ± 19.2%) and 20 healthy subjects were included in the study.
Pulmonary function testing and six-minute walk test (6MWT) were performed. Peripheral muscle strength was
measured with a hand-held dynamometer, peripheral muscle endurance was evaluated with sit-ups, squats and
modified push-ups tests. Fatigue perception was assessed using the Fatigue Impact Scale (FIS) and Fatigue Severity
Scale (FSS). General quality of life was determined with the Nottingham Health Profile (NHP), and cough-specific
quality of life was evaluated with the Leicester Cough Questionnaire (LCQ).
Results: Pulmonary functions, strength of shoulder abductor and flexor muscles, numbers of sit-ups and squats,
6MWT distance and 6MWT% were significantly lower in COPD patients than in healthy subjects (p < 0.05). FIS
psychosocial sub-dimension and total scores, NHP scores for all sub-dimensions except pain sub-dimension of the
COPD group were significantly higher than those of healthy subjects (p < 0.05). The LCQ physical, psychological and
social sub-dimensions and total scores were significantly lower in COPD patients than in healthy subjects (p < 0.05).
Conclusions: Pulmonary functions, peripheral muscle strength and endurance, exercise capacity and quality of life
were adversely affected in patients with COPD. There are greater effect of fatigue on psychosocial functioning and
general daily life activities and effect of cough on the quality of life in patients with COPD. This study supports the
idea that COPD patients must be evaluated in a comprehensive manner for planning pulmonary rehabilitation
programs.
Keywords: COPD, Exercise tests, Life quality, Muscle, Strength, Muscular fatigue, Coughs* Correspondence: ebrucalk85@hotmail.com
1Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences,
Hacettepe University, Samanpazari, Ankara 06100, Turkey
Full list of author information is available at the end of the article
© 2014 Calik-Kutukcu et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Calik-Kutukcu et al. BMC Pulmonary Medicine 2014, 14:6 Page 2 of 10
http://www.biomedcentral.com/1471-2466/14/6Background
Chronic obstructive pulmonary disease (COPD) is one of
the main causes of morbidity and mortality worldwide.
COPD is expected to be fourth in the causes of death and
seventh in the causes of loss of Disability-Adjusted Life
Years (DALY) worldwide by 2030 [1]. The disease is often
accompanied by concomitant systemic manifestations lead-
ing to a deterioration in functional capacity, worsening
dyspnea and decreased health-related quality of life, and
increased mortality [2].
Skeletal muscle weakness is one of the major systemic ef-
fects of COPD and associated with the loss of lean body
mass [2,3]. When comparing isometric quadriceps strength
between patients with COPD and age-and-sex-matched
healthy controls, a 20-30% loss in muscle strength and a
tendency to fatigue in the muscle were found [4]. Seven
controlled studies in COPD reported a loss of muscular
endurance greater than that of skeletal muscle strength [2].
The limitations to exercise in COPD reflect the abnormal-
ities of the respiratory, cardiovascular, neuromuscular and
neurosensory systems in highly variable combinations
with multifactorial interactions [5]. Exercise tolerance
as assessed by both a maximal exercise test and a 6-
minute walk test (6MWT) was shown to be lower than in
people with COPD than in sedentary healthy subjects [6].
Fatigue is one of the most distressing symptoms of this
group of diseases; it significantly impacts both functional
performance and quality of life [7-9]. Studies have shown
that skeletal muscle fatigue limits exercise tolerance in
50% of patients; fatigue was found to be increased in pa-
tients when compared to healthy controls [2,10-12]. The
physical and psychosocial effects of cough, a characteris-
tic symptom of COPD, may lead to a worsening of the
quality of life [1,13-15].
Even though it has been reported that the systemic ef-
fects of COPD impair peripheral muscle strength and
endurance, exercise tolerance and quality of life, studies
about practical evaluation methods for the peripheral
muscle endurance and perception of fatigue in pulmon-
ary rehabilitation programs of patients with COPD are
limited. There is no study that show the impairments of
COPD than healthy people with practical assessment
methods in pulmonary rehabilitation. While published
studies exist comparing COPD with other similar disease
groups for the effect of cough on quality of life, there
were not found any study comparing it with healthy sub-
jects. Therefore, this study aimed to evaluate peripheral
muscle strength and endurance, exercise capacity, fatigue
perception and both general and cough-specific quality of
life and to compare these results with those of a group of
healthy subjects. The primary objective of this study was
to show how much the systemic effects influence patients
with COPD than healthy subjects. The secondary objec-
tives of the study were to show discriminative propertiesof practical evaluation methods of systemic effects of
COPD than healthy controls and to investigate relation-
ships between dyspnea and fatigue perception, peripheral
muscle strength, general and cough-specific quality of life
in patients with COPD.
Methods
Twenty patients with COPD between the ages of 40–80
who were not taking antibiotics and had not made any
changes in their medications for at least three weeks
(mean FEV1 49.3 ± 19.2%, 5 female and 15 male) and a
group of age-and-sex-matched healthy subjects (4 female
and 16 male) were included in this cross-sectional study.
The patients who were redirected from the Hacettepe
University Hospitals, Department of Chest Diseases,
Ankara, Turkey for pulmonary rehabilitation and willing
to participate in the study were recruited. The healthy
subjects were volunteers without any lung, heart or sys-
temic disease or handicap in physical effort. Patients who
have physical disability to perform the tests and could not
cooperate for the tests were not included in the study.
The assessments were applied in the Hacettepe University,
Faculty of Health Sciences, Department of Physiotherapy
and Rehabilitation, Cardiopulmonary Rehabilitation Unit,
Ankara Turkey. The study was approved by the Ethical
Committee of Hacettepe University, patients and healthy
subjects who decided to participate in the study signed an
informed consent form.
The physical and sociodemographic characteristics of
all subjects were recorded. Dyspnea levels of subjects
were evaluated using the Modified Medical Research
Council (MMRC) Dyspnea Scale. This is a categorical
scale ranging from 0 to 4, where patients choose the
statement that best describes their dyspnea level from
five choices [16].
The pulmonary function test according to American
Thoracic Society/European Respiratory Society (ATS/ETS)
criteria was performed with a Spirolab III spirometer
(Spirolab, Medical International Research, Rome, Italy) in
the sitting position. The pulmonary function test results
were expressed as percentages of the expected values ad-
justed for age, height, body weight and sex [17].
Peripheral muscle strength (knee extensor, shoulder
abductor and flexor, and hand grip strength) was mea-
sured using a digital hand-held dynamometer (JTECH,
Medical Commander Powertrack II, USA). Peripheral
muscle strength testing was repeated three times for
each muscle and the mean value in Newtons (N) was re-
corded. The average values of the left and right sides
was then taken for statistical analysis. Peripheral muscle
endurance was assessed with a sit-ups test, a modified
push-ups test and a squat test. In the sit-ups test, pa-
tients were asked to lift up the trunk from the supine
position until the lower the angle of the scapula with
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possible. For the modified push-ups test, patients were
requested to only lift their trunk performing consecutive
elbow flexions and extensions in the push-up position
as quickly as possible. The squat test required the patient
to move as quickly as possible from a standing position to
a squatting position. Each tests were performed for 30 sec-
onds and the numbers of sit-ups, push-ups and squats
were recorded for analysis [18].
For the 6MWT, the patients were requested to walk
along a flat corridor as fast as they could in their walking
speed for six minutes. The test was administered twice
in the same day with a half-hour interval. Pre- and post-
test heart rate (HR) and oxygen saturation (SpO2) with a
pulse oxymeter (KPTS, Seoul, Korea) were recorded [19].
General and quadriceps fatigue and dyspnea perception
were assessed with Modified Borg Scale and pre- and
post-test scores were recorded [20]. For each patient,
result of the tests with the longest distance was used in
the statistical analysis [19]. The 6MWT distance was
expressed as percentages of the expected values from age
and sex (6MWT% of distance) [21].
After physical assessments, the patients and healthy
subjects answered questionnaires about fatigue and qual-
ity of life by themselves. The subjects answered ques-
tionnaires completed by selecting the most suitable
option for them. The fatigue perception of the subjects
were evaluated by the Fatigue Impact Scale (FIS) and the
Fatigue Severity Scale (FSS). FIS is a multidimensional
scale consisting of 40 questions to evaluate the patient’s
perception of the limitations caused by fatigue during the
last month in the physical (10 items), cognitive (10 items)
and psychosocial (20 items) functions. Each question is
answered by a choice ranging from a score of 0 (no prob-
lem) to 4 (extreme problems). Total score ranges between
0 and 160. High scores indicate a higher effect of fatigue
[22]. FSS is one of the most frequently used 9-item one-
dimensional scale developed for evaluating fatigue. Pa-
tients are asked to provide a score for each item on a
range from 1 (strongly disagreement) to 7 (strongly agree-
ment), a score of ≥4 indicates severe fatigue. FSS is reliable
and valid assesment tool for the Turkish population [23].
The Nottingham Health Profile (NHP) is a reliable
general quality of life questionnaire developed to pro-
vide a summary index on the patient’s perception of
emotional, social and physical health problems and
adaptation of the NHP was made for the Turkish people
(24). In this study, only the first part of this question-
naire was used to evaluate the subjects’ general quality
of life. This first part contains 38 items evaluating the
perception of limitation or discomfort, divided over six
sub-dimensions: energy level (3 items), pain (8 items),
emotional reaction (9 items), sleep (5 items), social iso-
lation (5 items), and physical abilities (8 items). Thetotal score for each section is 0–100. High scores indi-
cate worse quality of life [24].
The Leicester Cough Questionnaire (LCQ) is a valid
and reliable health status measure for adults with
chronic cough and patients with COPD that indicates
the effect of cough on quality of life and the efficacy of
cough-modifying agents during the last two weeks.
Adaptation of the LCQ was made for the Turkish people
(25). It contains a total of 19 items that are divided into
the physical (8 items), psychosocial (7 items) and social
(4 items) sub-dimensions. The answer to each items is
scored 1–7. Total score varies from 3 to 21. Low scores
on the LCQ indicate a higher effect of coughing on the
subject [25,26].
The statistical evaluation was performed using the
SPSS 15.0 statistical packet software for Windows [27].
Variables were descriptively expressed as mean ± standard
deviation, frequency and percentage. Normal distribution
was evaluated by the Shapiro-Wilk test and histograms
and the assumptions of the parametric tests were met by
the data. The continuous variables were compared using
the two-tailed Student’s t-test and variables determined by
counting were compared with the two-tailed Chi-squared
test. Correlations between dyspnea and fatigue perception,
peripheral muscle strength, general and cough-specific
quality of life in patients with COPD were evaluated using
the two-tailed Spearman’s correlation analysis as the con-
ditions required for parametric tests were not fulfilled
[28]. Correlations were characterized as “high” (r > 0.70),
“moderate” (r = 0.50–0.69), “low” (r = 0.26–0.49) and “little
or no correlation” (r = 0.00–0.25) [29]. Significance was
set at α < 0.05.
Results
Pulmonary function tests and dyspnea levels
The subjects’ characteristics are shown in Table 1. Phys-
ical and demographic characteristics of patients with
COPD and healthy subjects were similar. FVC, FEV1,
FEV1/FVC, FEF25-75% and PEF values of patients were sig-
nificantly lower than those of healthy subjects (p = 0.001,
Table 1). According to the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) criteria, 5% of patients
had mild, 45% moderate, 30% severe and 20% very severe
COPD [1]. The cigarette consumption (p = 0.024) and dys-
pnea levels (p = 0.001) were significantly higher in COPD
patients than in the healthy subjects (Table 1).
Peripheral muscle strength and endurance
Shoulder abductor (p = 0.012) and flexor muscle strengths
(p = 0.027) were also significantly lower for patients than
for healthy subjects (Table 2). There was no statistically sig-
nificant difference for knee extensor (p = 0.624) and hand
grip strengths (p = 0.523) between two groups (Table 2).
The numbers of sit-ups (p = 0.019) and squats (p = 0.009)
Table 1 Characteristics of COPD and healthy subjects
Characteristics COPD (n = 20) Healthy (n = 20) p
Age (years) 53 ± 5 [%95 Cl 52–56] 51 ± 6 [%95 Cl 47–54] 0.125
Sex (male/female) 15/5 16/4 1.0
Height (cm) 167±9 [%95 Cl 163–172] 166 ± 7 [%95 Cl 163–169] 0.496
Body weight (kg) 79 ± 18 [%95 Cl 69–86] 80 ± 10 [%95 Cl 72–82] 0.77
Body mass index (kg/m2) 28 ± 5 [%95 Cl 25–30] 27 ± 4 [%95 Cl 26–30] 0.389
FVC (%) 66 ± 19 [%95 Cl 56–75] 99 ± 13 [%95 Cl 91–105] 0.001*
FEV1 (%) 49 ± 19 [%95 Cl 39–58] 98 ± 12 [%95 Cl 90–103] 0.001*
FEV1/FVC (%) 63 ± 13 [%95 Cl 56–68] 82 ± 5 [%95 Cl 79–85] 0.001*
FEF25-75% (%) 28 ± 17 [%95 Cl 19–33] 89 ± 22 [%95 Cl 75–100] 0.001*
PEF (%) 57 ± 22 [%95 Cl 45–65] 105 ± 21 [%95 Cl 95–118] 0.001*
Smoking history (pack-years) 30 ± 24 [%95 Cl 19–42] 13 ± 15 [%95 Cl 5–22] 0.024*
MMRC (0–4) 1.4 ± 1.0 [%95 Cl 1–2] 0.3 ± 0.6 [%95 Cl −0.1-56] 0.001*
*Student’s t-test, p < 0.05.
Abbreviations: FVC forced vital capacity, FEV1 forced expiratory volume in one second, FEF25-75% forced expiratory flow 25–75%, PEF peak expiratory flow,
MMRC Modified Medical Research Council dyspnea scale.
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healthy subjects but no significant difference was found be-
tween two groups regarding the numbers of modified
push-ups (p = 0.065, Table 2).
Exercise capacity
The 6MWT distance (p = 0.006) and 6MWT% distance
(p = 0.006) were significantly lower in patients with COPD
than in the healthy subjects (Table 2). The changes in
SpO2 (p = 0.016), dyspnea (p = 0.001) and quadriceps fa-
tigue (p = 0.001) during 6MWT were significantly higher
in patients than healthy subjects (Table 2). No statisti-
cally significant difference was noted between groupsTable 2 Peripheral muscle strength and endurance, exercise c
COPD (n = 20
Shoulder abductors (N) 147 ± 38 [%95 Cl 13
Shoulder flexors (N) 168 ± 53 [%95 Cl 14
Knee extensors (N) 312 ± 54 [%95 Cl 27
Hand grip strength (N) 185 ± 34 [%95 Cl 15
Sit-ups (n) 16 ± 5 [%95 Cl 13
Squats (n) 17 ± 3 [%95 Cl 15
Modified push-ups (n) 17 ± 5 [%95 Cl 14
6MWT distance (m) 549 ± 92 [%95 Cl 52
6MWT% 98 ± 16 [%95 Cl 95
HR max. % 71 ± 13 [%95 Cl 63
ΔSpO2 (%) −3.4 ± 6.0 [%95 Cl −
Modified Borg-dyspnea (0–10) 2.7 ± 2.8 [%95 Cl 1
Modified Borg-fatigue (0–10) 1.0 ± 2.4 [%95 Cl −1
Modified Borg-quadriceps fatigue (0–10) 2.6 ± 2.1 [%95 Cl 1
*Student’s t-test, p < 0.05.
Abbreviations: 6MWT six minute walk test, HR heart rate, SpO2 oxygen saturation.for percentage of maximal HR (p = 0.708) or general fa-
tigue perception (p = 0.245) recorded during the test
(Table 2).Fatigue perception
Eleven patients (55%) with COPD reported having severe
fatigue. The FIS total (p = 0.048) and psychosocial sub-
dimension (p = 0.046) scores of patients with COPD were
higher in than those of healthy subjects, while there was
no statistically significant difference for the FIS physical
(p = 0.058) and cognitive sub-dimensions (p = 0.064) and
FSS scores (p = 0.503, Table 3).apacity in patients with COPD and healthy subjects
) Healthy (n = 20) p
5–171] 183 ± 48 [%95 Cl 161–206] 0.012*
7–199] 204 ± 45 [%95 Cl 183–225] 0.027*
7–336] 320 ± 44 [%95 Cl 300–341] 0.624
8–195] 195 ± 56 [%95 Cl 168–221] 0.523
–18] 19 ± 4 [%95 Cl 17–21] 0.019*
–18] 20 ± 4 [%95 Cl 18–22] 0.009*
–20] 19 ± 4 [%95 Cl 18–21] 0.065
6–611] 620 ± 60 [%95 Cl 592–648] 0.006*
–109] 111 ± 9 [%95 Cl 107–115] 0.002*
–79] 70 ± 8 [%95 Cl 67–74] 0.708
5-0.3] 0.2 ± 1.4 [%95 Cl −0.5-0.8] 0.016*
.1-3.9] 0.1 ± 0.3 [%95 Cl −0.0-0.2] 0.001*
.1-2.8] 0.4 ± 0.6 [%95 Cl 0.1-0.6] 0.245
.6-3.9] 0.3 ± 0.8 [%95 Cl −0.1-0.7] 0.001*
Table 3 Fatigue perception, general and cough-specific quality of life in patients with COPD and healthy people
COPD (n = 20) Healthy (n = 20) p
FIS
Physical 12 ± 11 [%95 Cl 7–17] 6 ± 8 [%95 Cl 2–10] 0.058
Cognitive 9 ± 8 [%95 Cl 5–13] 5 ± 7 [%95 Cl 1–8] 0.064
Psychosocial 20 ± 17 [%95 Cl 12–27] 97 ± 15 [%95 Cl 2–16] 0.046*
Total 41 ± 35 [%95 Cl 24–57] 20 ± 29 [%95 Cl 6–33] 0.048*
FSS 4 ± 1 [%95 Cl 3–5] 3 ± 2 [%95 Cl 2–4] 0.503
NHP
Energy level 43 ± 43 [%95 Cl 23–63] 8 ± 21 [%95 Cl −1-18] 0.03*
Pain 23 ± 28 [%95 Cl 10–35] 9 ± 14 [%95 Cl 2–15] 0.056
Emotional reaction 33 ± 27 [%95 Cl 20–46] 12 ± 19 [%95 Cl 3–22] 0.009*
Sleep 31 ± 29 [%95 Cl 17–44] 11 ± 19 [%95 Cl 2–19] 0.015*
Physical abilities 24 ± 21 [%95 Cl 14–34] 9 ± 12 [%95 Cl 3–15] 0.011*
Social isolation 27 ± 35 [%95 Cl 11–43] 5 ± 18 [%95 Cl −4-13] 0.018*
Total 180 ± 144 [%95 Cl 113–248] 51 ± 62 [%95 Cl 22–80] 0.001*
LCQ
Physical 5.3 ± 1.3 [%95 Cl 5–6] 6.7 ± 0.7 [%95 Cl 6–7] 0.001*
Psychological 5.2 ± 1.2 [%95 Cl 5–6] 6.1 ± 0.4 [%95 Cl 5.9-6.2] 0.006*
Social 5.7 ± 1.5 [%95 Cl 5–6] 6.9 ± 0.3 [%95 Cl 6.7-7] 0.004*
Total 16.3 ± 3.8 [%95 Cl 12–17] 19.6 ± 1.3 [%95 Cl 19–20] 0.001*
*Student’s t-test, p < 0.05.
Abbreviations: FIS Fatigue Impact Scale, FSS Fatigue Severity Scale, NHP Nottingham Health Profile, LCQ Leicester Cough Questionnaire.
Figure 1 The relationship between the MMRC and FIS
total scores.
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The NHP energy level (p = 0.03), emotional reaction
(p = 0.009), physical abilities (p = 0.011) and social isolation
(p = 0.018) sub-dimensions and the total scores (p = 0.001)
were significantly higher in COPD patients than in healthy
subjects (Table 3). The LCQ physical (p = 0.001), psycho-
logical (p = 0.006) and social (p = 0.004) sub-dimensions
and total scores (p = 0.001) of patients were significantly
lower than those of healthy subjects (Table 3).
Correlation analysis
Correlation analysis showed that the MMRC score was sig-
nificantly related with scores of the FIS physical (p = 0.001,
r = 0.70), cognitive (p = 0.002, r = 0.66), and psychosocial
sub-dimensions (p = 0.001, r = 0.72), the FIS total score
(p = 0.001, r = 0.69) (Figure 1) and the FSS total score
(p = 0.001, r = 0.78). A high degree of correlation was
seen between the FSS total score and shoulder abductor
strength (p = 0.001, r = −0.72) (Figure 2A), the FSS total
score and shoulder flexor strength (p = 0.001, r = −0.78)
(Figure 2B).
The NHP sleep sub-dimension score was highly corre-
lated with the LCQ total score (p = 0.001, r = −0.71).
The NHP physical abilities sub-dimension score was
significantly related with the LCQ physical (p = 0.007,
r = −0.58), psychological (p = 0.002, r = −0.65) and socialsub-dimensions (p = 0.007, r = −0.59) and total scores
(p = 0.001, r = −0.67). The NHP total score was likewise
in a statistically significant correlation with the LCQ total
score (p = 0.003, r = −0.63) (Figure 3) and scores of its
following sub-dimensions: physical (p = 0.013, r = −0.55),
psychological (p = 0.008, r = −0.58), and social (p = 0.02,
r = −0.52).
Figure 2 The relationship between upper extremity muscle strength and fatigue perception. (A) The shoulder abductors’ strength and FSS
score. (B) The shoulder flexors’ strength and FSS score.
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This study shows that upper extremity muscle strength,
abdominal and quadriceps muscle endurance and exer-
cise capacity were reduced compared to healthy subjects
in a group of patients with COPD mostly in GOLD
stages II and III. It also indicates that fatigue affects gen-
erally the daily life activities and psychosocial life of pa-
tients with COPD more negatively than healthy subjects,
the general quality of life are deteriorated in the patients.
The upper extremity muscle strength and dyspnea per-
ception were found to be associated with fatigue percep-
tion in COPD. The importance of this study lies in its
being the first to show that cough, a major symptom in
COPD patients, have a negative impact on the aspects of
physical, psychologic and social life of patients, leads to
a worsening of their quality of life as compared tohealthy subjects. The loss in cough-specific quality of life
was also shown to be related with that in general quality
of life.
Dyspnea perception
Hyperinflation reduces inspiratory capacity and increases
functional residual capacity in COPD. This leads to an
increase in the dyspnea perception during exercise and a
limitation of exercise capacity [1,13]. Higher MMRC and
dyspnea scores during 6MWT of our patients with
COPD are characteristic of the disease.
Peripheral muscle strength
Gosselink et al. observed a significant decline in periph-
eral muscle strength when compared 40 patients with
moderate to severe COPD (average FEV1 41 ± 19%) with
Figure 3 The relationship between the NHP and LCQ
total scores.
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elbow flexor strength were significantly higher than the
shoulder abductor strength and knee extensor muscle
strength was not different from hand grip and shoulder
abductor strength. It has been concluded that muscle
weakness does not affect all muscle groups similarly and
that peripheral muscle strength is not related with the
severity of airway obstruction in patients with stable
COPD [30]. It has been reported that unsupported arm
exercises result in a greater level of dyspnea than lower
extremity exercises even at low workloads, because they
interfere with the contribution of accessory inspiratory
muscles to the breathing work [31]. It has been thought
that the relative weakness of upper extremity muscles in
COPD patients compared to healthy controls in this
study can be explained with that patients who were
mostly at GOLD stages II and III may have limited arms
movements in order to prevent dyspnea. The similar
hand grip strength in both groups is compatible with the
report that distal upper extremity muscles are less af-
fected than proximal muscles in patients with moderate
to severe COPD [30]. Even though hand-held dynamom-
eters provide reliable test results, the tester’s strength is
particularly important in determining the strength of
large muscle groups and has a potential for underesti-
mating maximal muscle strength [32]. Published reports
in the literature indicate that quadriceps strength is an
important index of exercise capacity in COPD [33]. Dif-
ferences in the test methods, the absence of similarity in
the distribution of muscle weakness in the upper vs. the
lower extremity in patients with COPD, the finding that
the patients’ exercise capacity had reached up to 98% of
the expected values and the similar body compositions
in both groups can explain the similarity of quadriceps
strength in COPD patients and healthy volunteers in
our study.Peripheral muscle endurance and exercise capacity
Allaire et al. have shown that isometric quadriceps endur-
ance was significantly reduced in 29 COPD patients with
severe airway obstruction comparison to its value in
healthy subjects [34]. We found that numbers of squats in
30 seconds, which indicate quadriceps endurance, were
reduced compared to the healthy subjects in accordance
with the published reports [6,34-36]. As a result of motiv-
ational factors influencing peripheral muscle endurance
measurements and the heterogeneous distribution of
musculoskeletal dysfunction in COPD, data on peripheral
muscle function reported in the literature is variable. The
loss of endurance in the abdominal muscles of COPD
patients may be due to deconditioning secondary to in-
activity. It has shown that the mechanic efficiency of
submaximal arm exercises was substantially unchanged
compared to controls and the upper extremity exercise
tolerance was clearly higher than that of the lower limbs
in patients with stable COPD [37]. In conformity with this
finding, our study also showed that the upper extremity
muscle endurance, as indicated by the modified push-ups
test, was maintained in the patients. Our study showed
the feasibility of using these endurance tests to differenti-
ate effects on regional endurance that may be easier to
apply in the clinic than other published endurance evalu-
ation methods in COPD. Even though COPD patients
underperformed with respect to the controls at the end of
6MWT, they nonetheless remained within normal limits.
The finding that exercise capacity remained normal in
these cases with preserved quadriceps strength [38] sup-
ports the idea that skeletal muscle weakness plays an im-
portant role in exercise limitation [33].
Fatigue perception
Lewko et al. have shown that the subjective perception
of fatigue in COPD patients, as evaluated by the Multidi-
mensional Fatigue Inventory (MFI-20), was substantially
higher than in healthy people [39]. It has been reported
in a study of 151 patients with COPD that patients re-
port fatigue as being more frequent, in longer duration
and greater severity and that their physical and psycho-
social limitations due to fatigue, as assessed by FIS, are
relatively greater than people in the general population
[8]. Our study indicated that majority of patients with
COPD have severe fatigue and fatigue affects the general
daily life activities and psychosocial life of patients defin-
itely more than those of healthy subjects. This finding is
compatible with the reports in the literature about fa-
tigue in COPD [8,39,40]. Theander et al. have found that
COPD patients reporting severe fatigue exhibit more
pronounced fatigue-related functional limitations than
those patients who are reporting moderate fatigue [8].
The finding that there is no significant difference be-
tween the groups for the FIS sub-dimensions that assess
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tions is thought to be due to the majority of the patients
in GOLD II-III stage and their mild and similar fatigue
severity level (mean FSS scores <4) with controls. Mental
functions are one of the extremely complex brain func-
tions and their evaluation must be multidimensional.
The cognitive sub-dimension of FIS provides a gross as-
sessment of fatigue effect on cognitive function and it
may have been insufficient for the evaluation of influ-
ence of fatigue on cognitive functions.
In a study in patients with moderate and severe COPD,
there was found a high correlation between the levels of
fatigue and dyspnea (r = 0.74, p < 0.001) in patients report-
ing moderate fatigue. Dyspnea, depressive mood and sub-
jective sleep quality were showed to explain 42% of the
change in fatigue. The authors explained the relationship
between dyspnea and fatigue by the hypothesis that
COPD-related fatigue results from an increase in respira-
tory effort and from physical deconditioning [9]. Even
though the mechanisms of the relationship are still un-
clear, our findings show the presence of a correlation be-
tween dyspnea and fatigue in conformity with existing
studies in this field [9,41]. Lewko et al. find that depres-
sion, muscle strength and exercise desaturation explain
62% of the variability in the MFI-20 general fatigue sub-
dimension score [39]. The high degree of correlation be-
tween peripheral muscle strength and the severity of
fatigue in our study supports this finding and pulmonary
rehabilitation programs should also consider peripheral
muscle weakness beside dyspnea-reduction approaches in
the treatment of fatigue. This study guides to literature by
showing that the FIS and FFS questionnaires are more
practical, easier to use compared to physiological fatigue
assessment methods and distinctive for fatigue evaluation.
Quality of life
The negative effects of COPD on multiple aspects of
general quality of life, as evaluated by NHP, supports the
published data that indicate a lower quality of life in
COPD patients when compared to other chronic disease
and healthy subjects [11,42,43]. Studies on chronic respira-
tory symptoms shows a chronic cough and/or sputum pro-
duction prevalence in the general adult population varying
from 4% in nonsmokers to 50% in patients with COPD
[44]. It has been suggested that patients who complain
from chronic cough are generally affected by psychosocial
complications as well as physical and psychosocial adverse
effects [14,15]. Chronic cough and sputum production in
COPD patients are related with loss of lung function and
increased frequency of exacerbations which more severely
worsen quality of life [44]. The cough-specific quality of life
of patients with COPD complaining from chronic cough in
this study (of whom 10% had non-productive and 50% pro-
ductive cough) were significantly more severely affectedthan healthy subjects who reported a history of smoking
and complaint from acute productive cough (10% of
healthy subjects). This findings supports the published
reports which show that cough affects quality of life in
COPD patients by leading to physical and psychosocial
complications, and the effect on psychosocial aspect of
quality of life is more severe in patients with chronic
cough than in healthy subjects complaining from acute
cough [15,42,45]. Health-related quality of life question-
naires are the best method for expressing cough inten-
sity from the patient’s viewpoint, subjective responses
by the patients inform about the frequency and intensity
of the cough [14]. The study also shows that the multi-
dimensional LCQ questionnaire which is valid, reliable
and responsive instrument [26], may be used as a dis-
tinctive questionnaire for evaluating the effect of cough
on quality of life.
French et al. have demonstrated that the physical and
psychosocial adverse effects of chronic, persistent cough
have significant psychosocial and physical effects on gen-
eral quality of life as assessed by the Sickness Impact
Profile (SIP), in particular in the categories of ambula-
tion, social interaction, sleep and rest, work, home man-
agement, recreation and pastimes. A multiple stepwise
regression analysis showed that cough-related tiredness
explained approximately 30% of the variability in SIP
psychosocial sub-dimension and total scores, and that
the need for reassurance that nothing was seriously the
matter related to cough, stopped going to the movies
and spouse unable to tolerate the cough explained 40%
of the variability in the SIP physical sub-dimension score
[15]. Another study performed in 54 patients with COPD
found significant correlations between the corresponding
sub-dimensions of the LCQ and the Saint George’s Re-
spiratory Questionnaire [26]. The findings that moderate
and high correlations between the sleep and physical abil-
ities sub-dimensions of the NHP and the corresponding
sub-dimensions of the LCQ in this study support the ob-
servations showing that cough is related with general
quality of life by leading to physical complications and
sleep disturbances. While health-related quality of life
questionnaires focus exclusively on the fields directly af-
fected by health, health status questionnaires include
physical, emotional, social, health and functional aspects.
The use of the LCQ in evaluating patients with COPD will
provide the clinician a general idea about the patients’
general quality of life.
Limitations
The limitations of our study are the insufficient number
of subjects in both study groups, the composition of the
healthy subjects group that included mainly sedentary
office workers and some of them had a history of smok-
ing, no adjustment for key variables as socioeconomic
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patients from every stage uniformly and the failure to
use computerized dynamometers which provide more
precise results of quadriceps muscle strength.
Conclusions
In conclusion, this study showed that in a patient group
with mainly moderate and severe COPD experience a
loss of peripheral muscle strength and endurance, exercise
capacity and general quality of life compared to healthy
controls. Additionally, the effect of dyspnea perception
and fatigue on general daily life activities were increased in
comparison to healthy subjects; dyspnea perception and
peripheral muscle weakness are related with the percep-
tion of fatigue. Coughing, which is an important symptom
related with exacerbation and mortality in COPD patients,
negatively affects quality of life by creating physical and
psychosocial complications and this state also decreases
general quality of life. The strength of this study is to show
that multidimensional evaluations must be done in order
to plan pulmonary rehabilitation programs for COPD
patients. We think that showing the distinctive charac-
ters of assessment parameters for patients with COPD
may guide the selection of the methods for evaluation
and goal-appropriate treatment within pulmonary re-
habilitation programs.
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